This scientific poster explains how the CellXpress.ai™ Automated Cell Culture System streamlines complex cell culture operations, saving human labor and increasing productivity.
Image Credit: Molecular Devices
When combined with the ImageXpress® HCS.ai High Content Screening System, it allows for high-speed, high-quality imaging of 3D intestinal organoids, which aids in accurate phenotypic analysis.
The use of machine learning methods in IN Carta® Software automates the detection and quantification of chemical effects, resulting in more reproducible and scalable toxicity assessments.
This novel strategy uses AI-powered data analysis to enhance therapeutic outcomes and speed up drug development.
Download the Poster
About Molecular Devices UK Ltd
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.